Global Custom Monoclonal Antibody Services
Monoclonal antibodies are originated from identical immune cells which are duplicated from single parental cell. Monoclonal antibodies specifically bind to particular antigen as they can recognise the known epitope present on antigen. The monoclonal antibodies can be produce either by in vivo conditions using experimental animals or else by in-vitro conditions using tissue culture. Custom monoclonal antibodies are particularly produced against predicided peptide or protein antigen to which they have increased specificity & affinity. Owing to their high specificity monoclonal antibodies has been revolutionary invention in the field of medical where it can directly use against tumour cells to treat the cancer.  

Increasing necessity of specialized medicine and surging investment of government in research & development is the key factor driving the growth of custom monoclonal antibody market. Other aspect such as prevalence of immunological disorders, high occurrence of chronic disease and infections is boosting the market for future growth. Moreover increasing awareness level and advancement in technology are vital factors responsible for market growth. Nevertheless high cost and strict guidelines in the production of monoclonal antibodies might restrict the market for further growth. In addition mABs being specific in nature have limited number of target and they do not penetrate the cells instead just interact with cells hence mABs cannot be used in broader sense treatment hampering the market growth in future. Custom monoclonal antibodies have great opportunity to establish its own market as it does not harm healthy cells like chemotherapy but only targeted or diseased cells. Increased application of mABs in drug development programme gives the opportunity to several vendors to enter the market for the purpose of revenue generation that will contribute to the overall market growth. 

The global custom monoclonal antibody market is separated on the basis of its type, application, end user and region. Considering type it is divided into rat custom monoclonal antibodies and rabbit custom monoclonal antibodies. On the basis of application it is diversely segmented into diagnostic & therapeutic applications, biochemical analysis, cancer treatment, protein purification, hormonal disorder, infectious & cardiovascular disease. In concern to end user the market is segmented into hospitals & laboratories, research & academic organizations, pharmaceuticals & biotechnological companies.

Geographically market is analysed across North America, Europe, Asia-Pacific and LAMEA. America dominates the market owing to highly advanced technology, increased expenditure on healthcare and patient population followed by Europe. Europe ranks second on the listing as government bodies rising investment for R&D Purpose. Considering poverty and being slow developing country Middle East and Africa holds the least share in the market of custom monoclonal antibody service.

Top key players of the market are Thermofischer, genscript, Abnova Corporation, Creative Biolabs, Abcam Plc, Proman biotechnologies, Envigo, Merck & Co.Inc., Novartis International, Pfizer, GlaxoSmithKline Plc.
Recently in June 27, 2017 Genscript which is now one of two major companies has officially launched
Custom rabbit monoclonal antibody service that is difficult to hybridize.  These customized rabbit monoclonal antibodies can be used against various challenging targets including nanobodies, membrane receptors, anti-ID antibodies, small molecule compounds and antibody drugs. 

Key Segments of the Mushroom Market
Global Custom Monoclonal Antibody- By Type
 Rat Custom Monoclonal Antibody
 Rabbit Custom Monoclonal Antibody
 Mice Custom Monoclonal Antibody
 Others
Global Custom Monoclonal Antibody-By Application
 Diagnostic & Therapeutic 
 IL-1 Blockers
 Cancer Treatment 
 TNF Inhibitors
 Neurology & Cardiovascular Disease
Global Custom Monoclonal Antibody-By End User
 Hospitals & laboratories
 Research & Academic Organizations
 Pharmaceuticals & Biotechnological companies

Global Custom Monoclonal Antibody-By Region
North America
 US
 Canada
 Mexico
Europe
 Germany 
 France
 UK
 Italy
 Spain
 Rest of Europe
Asia-Pacific
 Japan
 China
 India
 Australia
 Rest of APAC
LAMEA
 Middle East
 Africa
 Brazil

Market Key Players
 Thermo Fischer
 Genscript
 Abnova Corporation
 Creative Biolabs
 Abcam Plc
 Proman biotechnologies
 Envigo
 F. Hoffmann-La Roche
 Johnson & Johnson
 BMS
 AbbVie
Other Players
 GlaxoSmithKline Plc.
 Amgen Inc.
 Abbott Laboratories
 Novartis International
 Pfizer